KR102527953B9 - Microorganism expressing heterologous protein and use thereof - Google Patents
Microorganism expressing heterologous protein and use thereofInfo
- Publication number
- KR102527953B9 KR102527953B9 KR1020220047195A KR20220047195A KR102527953B9 KR 102527953 B9 KR102527953 B9 KR 102527953B9 KR 1020220047195 A KR1020220047195 A KR 1020220047195A KR 20220047195 A KR20220047195 A KR 20220047195A KR 102527953 B9 KR102527953 B9 KR 102527953B9
- Authority
- KR
- South Korea
- Prior art keywords
- heterologous protein
- expressing heterologous
- microorganism expressing
- microorganism
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220047195A KR102527953B1 (en) | 2021-03-29 | 2022-04-15 | Microorganism expressing heterologous protein, and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210040065A KR102635553B1 (en) | 2018-12-28 | 2021-03-29 | Microorganism expressing heterologous protein, and use thereof |
KR1020220047195A KR102527953B1 (en) | 2021-03-29 | 2022-04-15 | Microorganism expressing heterologous protein, and use thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210040065A Division KR102635553B1 (en) | 2018-12-28 | 2021-03-29 | Microorganism expressing heterologous protein, and use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
KR20220050869A KR20220050869A (en) | 2022-04-25 |
KR102527953B1 KR102527953B1 (en) | 2023-05-03 |
KR102527953B9 true KR102527953B9 (en) | 2023-09-07 |
Family
ID=75444111
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220047195A KR102527953B1 (en) | 2021-03-29 | 2022-04-15 | Microorganism expressing heterologous protein, and use thereof |
KR1020220047194A KR102527954B1 (en) | 2021-03-29 | 2022-04-15 | Microorganism expressing heterologous protein, and use thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220047194A KR102527954B1 (en) | 2021-03-29 | 2022-04-15 | Microorganism expressing heterologous protein, and use thereof |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR102527953B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU682638B2 (en) * | 1995-06-09 | 1997-10-09 | ILS, Inc. | Peptide, bronchodilator and blood flow ameliorant |
US6849714B1 (en) * | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
WO2011148219A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
CN108753670A (en) * | 2018-05-28 | 2018-11-06 | 西北工业大学 | Multi-functional compound micro-ecological preparation nanometer selenium-recombinant expression vasoactive intestinal peptide-Lactococcus lactis and preparation method |
-
2022
- 2022-04-15 KR KR1020220047195A patent/KR102527953B1/en active IP Right Grant
- 2022-04-15 KR KR1020220047194A patent/KR102527954B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220050869A (en) | 2022-04-25 |
KR102527954B9 (en) | 2023-09-07 |
KR102527954B1 (en) | 2023-05-03 |
KR20220050124A (en) | 2022-04-22 |
KR102527953B1 (en) | 2023-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288373A (en) | Flt3l-fc fusion proteins and methods of use | |
SG11202103024RA (en) | Culture material and use thereof | |
EP3763812A4 (en) | Argonaute protein mutant and use thereof | |
EP4074832A4 (en) | Method for creating new gene in organism and use thereof | |
EP3950720A4 (en) | Fusion protein and use thereof | |
ZA202007822B (en) | Immunodominant proteins and fragments in multiple sclerosis | |
ZA202101250B (en) | Novel crispr-associated protein and use thereof | |
EP3987021A4 (en) | Optimized protein linkers and methods of use | |
EP3998277A4 (en) | Novel il-10 variant protein and use thereof | |
EP4119523A4 (en) | Ferrite material, preparation method therefor and use thereof | |
EP3868403A4 (en) | Taci-fc fusion protein and use thereof | |
EP4100050A4 (en) | Leptospiral proteins and uses thereof | |
EP3998282A4 (en) | Novel fusion protein and use of same | |
KR102527954B9 (en) | Microorganism expressing heterologous protein and use thereof | |
EP3966321A4 (en) | Asx-specific protein ligases and uses thereof | |
EP3999549A4 (en) | Sialidase-pd-l1-antibody fusion proteins and methods of use thereof | |
KR102238519B9 (en) | Microorganism expressing heterologous protein and use thereof | |
EP4056197A4 (en) | Tumor-specific polypeptide sequence and use thereof | |
IL311185A (en) | Mog-binding proteins and uses thereof | |
GB202111039D0 (en) | Materials and methods | |
ZA202110190B (en) | Protein tapyl1, coding gene and use thereof | |
GB202101160D0 (en) | Materials and methods | |
EP3978513A4 (en) | Efficient ppr protein production method and use thereof | |
EP4028080A4 (en) | Hydratable bone material and methods of use | |
EP4032611A4 (en) | Composite material and use thereof in desulfurization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |